BISWARUP GHOSH: Open Payments
NPI 1730333857 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,093 in 27 payments from 11 companies in 2025. Trend: 2023 $125 · 2024 $349 · 2025 $1,093
Food & beverage: $1,093
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $283 |
| Vanda Pharmaceuticals Inc. | 7 | $241 |
| Janssen Scientific Affairs, LLC | 1 | $131 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $123 |
| Teva Pharmaceuticals USA, Inc. | 5 | $104 |
| Alkermes, Inc. | 2 | $59 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| Neurocrine BioSciences, Inc. | 2 | $34 |
| ABBVIE INC. | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
Products named: COBENFY, FANAPT, INVEGA SUSTENNA, CAPLYTA, AUSTEDO XR, Auvelity, UZEDY, INGREZZA.
Industry payments across NY — which companies pay providers there.
